CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-15 | HERSHBERG ROBERT Director | Option exercise · Stock Option (Right to Buy) | −2,000 | 63,000 | ||
| 2020-10-15 | LO FRANCIS Chief People Officer | Option exercise | +2,000 | $7.80 | $16K | 2,000 |
| 2020-10-15 | LO FRANCIS Chief People Officer | Sale | −2,000 | $51.51 | $103K | 0 |
| 2020-10-15 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (Right To Buy) | −2,000 | 165,000 | ||
| 2020-10-14 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +11,100 | $6.32 | $70K | 11,779 |
| 2020-10-14 | ROBINS HARLAN S Chief Scientific Officer | Sale | −7,620 | $51.87 | $395K | 4,159 |
| 2020-10-14 | ROBINS HARLAN S Chief Scientific Officer | Sale | −3,480 | $52.84 | $184K | 679 |
| 2020-10-14 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −11,100 | 289,200 | ||
| 2020-10-14 | GRIFFIN MICHELLE RENEE Director | Option exercise | +12,000 | $7.80 | $94K | 12,000 |
| 2020-10-14 | GRIFFIN MICHELLE RENEE Director | Sale | −4,649 | $52.48 | $244K | 7,351 |
| 2020-10-14 | GRIFFIN MICHELLE RENEE Director | Sale | −7,351 | $53.07 | $390K | 0 |
| 2020-10-14 | GRIFFIN MICHELLE RENEE Director | Option exercise · Stock Option (Right to Buy) | −12,000 | 113,000 | ||
| 2020-10-14 | Pellini Michael J Director | Option exercise | +50,000 | $6.55 | $328K | 50,000 |
| 2020-10-14 | Pellini Michael J Director | Sale | −28,255 | $51.89 | $1.5M | 21,745 |
| 2020-10-14 | Pellini Michael J Director | Sale | −21,745 | $52.95 | $1.2M | 0 |
| 2020-10-14 | Pellini Michael J Director | Option exercise · Stock Option (Right to Buy) | −50,000 | 100,000 | ||
| 2020-10-12 | LO FRANCIS Chief People Officer | Option exercise | +25,000 | $7.80 | $195K | 25,000 |
| 2020-10-12 | LO FRANCIS Chief People Officer | Sale | −25,000 | $52.80 | $1.3M | 0 |
| 2020-10-12 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (Right To Buy) | −25,000 | 167,000 | ||
| 2020-10-08 | ROBINS CHAD M CEO and Chairman | Option exercise | +24,260 | $0.33 | $8K | 1,802,440 |
Page 86 of 120 · 2,386 trades